BFM
CYTR

Boston Financial Management’s CytRx Corp CYTR Stock Holding History

Boston Financial Management’s Portfolio CYTR Stock Details CYTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-4,333
Closed -$11K – 270
2017
Q3 		$11K Hold
4,333
– – ﹤0.01% 259
2017
Q2 		$16K Hold
4,333
– – ﹤0.01% 270
2017
Q1 		$12K Hold
4,333
– – ﹤0.01% 275
2016
Q4 		$10K Hold
4,333
– – ﹤0.01% 270
2016
Q3 		$15K Hold
4,333
– – ﹤0.01% 254
2016
Q2 		$58K Buy
+4,333
New +$72.1K ﹤0.01% 246

Other funds holding CYTR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
PHS
Pekin Hardy Strauss Chicago, Illinois $1.14B AUM 37.36% 1-Year Est. Return

Boston Financial Management's CYTR Position: Q4 2017 in Review

Boston Financial Management sold out of CytRx Corp (CYTR) in Q4 2017, closing a stake of 4,333 shares — an estimated $11K sold.

Boston Financial Management first reported a position in CYTR in Q2 2016 and held it in 6 quarters. The position peaked at $58K in Q2 2016. 33 funds tracked by Wall St. Rank hold CYTR as of Q4 2017.

  • Boston Financial Management reported no remaining CytRx Corp position as of Q4 2017 after selling out during the quarter.
  • Boston Financial Management sold 4,333 CytRx Corp shares in Q4 2017, an estimated $11K.
  • Boston Financial Management first reported a position in CytRx Corp in Q2 2016 and held it in 6 quarters.
  • Boston Financial Management's CytRx Corp position peaked at $58K in Q2 2016.
  • 33 funds tracked by Wall St. Rank held CytRx Corp as of Q4 2017.

Based on Boston Financial Management's 13F filing for Q4 2017, filed 5 Feb 2018.